Eli Lilly weight loss therapy added to Hims & Hers platform (update)
Shares of Hims & Hers Health (NYSE:HIMS) traded higher on Tuesday after the telehealth company announced the addition of ...
Where Will Eli Lilly Be in 1 Year?
Lately, however, Eli Lilly's stock has cooled. Shares have been essentially flat since July 2024. The market for GLP-1 ...
The Financial Express2d
Eli Lilly sues two companies over illegal copies of weight-loss drugs
Lilly has already sued more than two dozen medical spas, wellness centers and compounding pharmacies for selling products ...
Hims & Hers adding access to generic liraglutide, branded tirzepatide
Craig Primack stated in part: “In my experience of treating thousands of people, lasting results come from focusing on the individual, not just the condition. This simple belief has shaped the way ...
Nasdaq1d
Eli Lilly Sues Pharmacies Over Unauthorized Tirzepatide Compounding
(RTTNews) - Eli Lilly And Co. (LLY) filed lawsuits Tuesday against Strive Pharmacy and Empower Pharmacy, accusing them of unlawfully compounding and selling tirzepatide, the active ingredient in ...
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...
Citi sees high price of Tirzepatide on Hims & Hers being ‘prohibitive’
Citi analyst Daniel Grosslight says Hims & Hers traded up 10% yesterday after Bloomberg noted the company is now offering branded ...
STAT1d
Pharmalittle: We’re reading about a ‘miracle’ HIV drug program, Lilly going after compounders, and more
The Trump administration’s cuts to a global AIDS relief program threaten to upend rollout of a groundbreaking HIV prevention ...
Investor's Business Daily on MSN21h
Hims Dives After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch
Hims stock reversed lower Wednesday as analysts laid out low expectations for Him & Hers' branded tirzepatide.